NEW YORK, NY / ACCESSWIRE / April 22, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Tivity Health, Inc. (NASDAQ:TVTY)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/tivity-health-inc-loss-submission-form?prid=6138&wire=1
Lead Plaintiff Deadline: April 27, 2020
Class Period: March 8, 2019 to February 19, 2020
Allegations against TVTY include that: (i) following the Nutrisystem Acquisition, Tivity’s Nutrition segment faced significant operational challenges; (ii) the foregoing would foreseeably have a significant impact on Tivity’s revenues; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/inovio-pharmaceuticals-inc-loss-submission-form?prid=6138&wire=1
Lead Plaintiff Deadline: May 12, 2020
Class Period: February 14, 2020 to March 9, 2020
According to a filed complaint, throughout the class period, defendants made misleading statements about the company’s development of a purported vaccine for the novel coronavirus, artificially inflating the company’s share price and resulting in significant investor losses.
Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/norwegian-cruise-line-holdings-ltd-loss-submission-form?prid=6138&wire=1
Lead Plaintiff Deadline: May 11, 2020
Class Period: February 20, 2020 to March 12, 2020
Allegations against NCLH include that: (1) the Company was employing sales tactics of providing customers with unproven and/or blatantly false statements about COVID-19 to entice customers to purchase cruises, thus endangering the lives of both their customers and crew members; and (2) as a result, Defendants’ statements regarding the Company’s business and operations were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: Levi & Korsinsky LLP